Abstract

Fibroblasts are a key stromal cell in the tumor microenvironment (TME) and promote tumor growth via release of various growth factors. Stromal fibroblasts in cancer, called cancer-associated fibroblasts (CAF), are related to myofibroblasts, an activated form of fibroblast. While investigating the role of stroma fibroblasts on radiation-related carcinogenesis, it was observed following long-term fractionated radiation (FR) that the morphology of human diploid fibroblasts changed from smaller spindle shapes to larger flat shapes. These cells expressed smooth muscle actin (α-SMA) and platelet-derived growth factor receptors, markers of myofibroblasts and CAFs, respectively. Long-term FR induces progressive damage to the fibroblast nucleus and mitochondria via increases in mitochondrial reactive oxygen species (ROS) levels. Here, it is demonstrated that long-term FR-induced α-SMA-positive cells have decreased mitochondrial membrane potential and activated oxidative stress responses. Antioxidant N-acetyl cysteine suppressed radiation-induced mitochondrial damage and generation of myofibroblasts. These results indicate that mitochondrial ROS are associated with the acquisition of myofibroblasts after long-term FR. Mechanistically, mitochondrial ROS activated TGFβ signaling which in turn mediated the expression of α-SMA in radiation-induced myofibroblasts. Finally, in vivo tumor growth analysis in a human tumor xenograft model system revealed that long-term FR-induced myofibroblasts promote tumor growth by enhancing angiogenesis.Implications: Radiation affects malignant cancer cells directly and indirectly via molecular alterations in stromal fibroblasts such as activation of TGFβ and angiogenic signaling pathways. Mol Cancer Res; 16(11); 1676-86. ©2018 AACR.

Highlights

  • Ionizing radiation offers numerous clinical benefits for diagnosis and therapy

  • Myofibroblast induction by long-term fractionated radiation (FR) We investigated the effect of exposure to FR for 31 days in human lung fibroblasts, TIG-3, and MRC-5

  • A, Images of a smooth muscle actin (a-SMA) staining in nonirradiated control cells (0FR) and TIG-3 cells exposed to 0.01 FR for 31 days (0.01FR) with/without NAC treatment

Read more

Summary

Introduction

Ionizing radiation offers numerous clinical benefits for diagnosis and therapy. Radiotherapy (RT) is one of the most widely used therapies for cancer treatment. In patients being treated with RT, the radiation dose is limited by the tolerance of healthy tissue. To preserve normal tissue function, treatment is delivered in multiple small fractions of radiation (fractionated radiation, FR) with dose of around 2 Gy for 5 to 7 weeks [1]. Technological advances have significantly improved clinical outcomes of RT by enabling increased radiation doses directed very at a tumor. The late effects of cancer treatment such as radiation-induced second malignancies are a serious public health issue [1]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call